Company's annual revenue growth of 30.73% outperformed its 3 year CAGR of 11.12%. (Source: Standalone Financials)
Vilin Bio Med Share Price
Vilin Bio Med Share Pri...
Vilin Bio Med share price insights
Company has spent 4.97% of its operating revenues towards interest expenses and 5.09% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Vilin Bio Med Ltd. share price moved down by -2.32% from its previous close of Rs 19.45. Vilin Bio Med Ltd. stock last traded price is 19.00
Share Price Value Today/Current/Last 19.00 Previous Day 19.45
Key Metrics
PE Ratio (x) | 0.00 | ||||||||||
EPS - TTM (₹) | 0.00 | ||||||||||
MCap (₹ Cr.) | 26.51 | ||||||||||
Sectoral MCap Rank | 373 | ||||||||||
PB Ratio (x) | 1.16 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| - | ||||||||||
VWAP (₹) | 19.50 | ||||||||||
52W H/L (₹) |
Vilin Bio Med Ltd. Share Price Returns
1 Day | 2.64% |
1 Week | 5.41% |
1 Month | 14.71% |
3 Months | N.A. |
1 Year | -14.66% |
3 Years | N.A. |
5 Years | N.A. |
Vilin Bio Med News & Analysis
We don't have any recent updates for this stock. We suggest you to explore other sections.
Vilin Bio Med Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Vilin Bio Med Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 30.73% outperformed its 3 year CAGR of 11.12%. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 4.97% of its operating revenues towards interest expenses and 5.09% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 Total Revenue 16.13 12.34 11.22 11.72 Total Revenue Growth (%) 30.73 9.97 -4.26 -30.35 Total Expenses 15.90 10.56 11.17 11.56 Total Expenses Growth (%) 50.67 -5.54 -3.32 -30.50 Profit after Tax (PAT) 0.16 1.25 0.03 0.12 PAT Growth (%) -86.96 3,616.42 -72.38 -25.22 Operating Profit Margin (%) 6.39 19.73 4.91 5.14 Net Profit Margin (%) 1.02 10.11 0.29 1.03 Basic EPS (₹) 0.12 1.25 0.10 0.37 Annual FY 2024 FY 2023 FY 2022 FY 2021 Total Assets 32.40 17.68 13.56 13.89 Total Assets Growth (%) 83.26 30.38 -2.38 -0.86 Total Liabilities 9.56 7.01 6.16 6.53 Total Liabilities Growth (%) 36.38 13.80 -5.67 -3.40 Total Equity 22.84 10.68 7.40 7.36 Total Equity Growth (%) 113.86 44.32 0.54 1.66 Current Ratio (x) 2.01 2.04 2.21 2.19 Total Debt to Equity (x) 0.30 0.46 0.72 0.75 Contingent Liabilities 0.00 - - - All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 Net Cash flow from Operating Activities -5.30 -1.66 0.21 -1.00 Net Cash used in Investing Activities 0.32 -0.03 - - Net Cash flow from Financing Activities 10.99 1.68 -0.22 0.98 Net Cash Flow 6.01 0.00 -0.01 -0.02 Closing Cash & Cash Equivalent 6.05 0.03 0.04 0.05 Closing Cash & Cash Equivalent Growth (%) 0.00 -11.54 -16.13 -30.18 Total Debt/ CFO (x) -1.29 -2.97 25.41 -5.51 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 Return on Equity (%) 0.71 11.65 0.45 1.64 Return on Capital Employed (%) 4.37 21.73 6.72 7.15 Return on Assets (%) 0.50 7.04 0.24 0.87 Interest Coverage Ratio (x) 1.45 4.01 1.52 1.95 Asset Turnover Ratio (x) 0.63 0.79 0.82 0.84 Price to Earnings (x) 163.93 - - - Price to Book (x) 1.16 - - - EV/EBITDA (x) 23.91 - - - EBITDA Margin (%) 7.21 21.09 6.86 7.34
Vilin Bio Med Ltd. Peer Comparison
Vilin Bio Med Ltd. Stock Performance
Ratio Performance
Choose from Peers
Choose from Stocks
- There’s no suggested peer for this stock.
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...- See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Vilin Bio Med Board Meeting/AGM
Vilin Bio Med Dividends
- Others
Meeting Date Announced on Purpose Details May 29, 2024 May 21, 2024 Board Meeting Audited Results Nov 10, 2023 Oct 30, 2023 Board Meeting Quarterly Results Sep 23, 2023 Aug 24, 2023 AGM - Dividend announcements are not available.
No other corporate actions details are available.
About Vilin Bio Med
Executives
Auditors
- VP
Viswa Prasad Sadhanala
Managing DirectorABAnuj Bajpai
Whole Time DirectorPKPadmaja Kalyani Sadhanala
Non Executive DirectorRKRakesh Kumar Chandak
Independent DirectorShow More - PPKG & Co.
Industry
Key Indices Listed on
Nifty SME Emerge,
Address
Sy No.115/GF/J, Hanumanji Colony,Brig Sayeed Road, Bowempally,hyder, Telangana - 500003
More Details
Trending in Markets
Vilin Bio Med Ltd. Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.